32 Biosciences is a pioneering company transforming gut health through science and innovation. Founded on over two decades of research at The University of Chicago and the University of Wisconsin-Madison, it was established by three renowned scientists: Dr. John Alverdy, Dr. Gene Chang, and Dr. Joseph Pierre. Their collaborative insights into the gut microbial organ have driven the company's mission to develop innovative microbiome-based diagnostics and therapeutic solutions to address unmet medical needs.

The company's vision is to establish the gut microbiome as the sixth vital organ and lead the microbiome sector with advanced diagnostic tools and microbiome-based interventions globally. Its mission is to revolutionize healthcare by defining, diagnosing, and restoring the functional health of the gut microbiome, thereby preventing and treating chronic diseases and improving health span and longevity.